09-12-2025 17:31 via drugs.com

ASH: Lifestyle Intervention Feasible During Chemo for Lymphoma

TUESDAY, Dec. 9, 2025-- A lifestyle intervention is feasible for patients with lymphoma undergoing chemotherapy, according to a study presented at the annual meeting of the American Society of Hematology, held from Dec. 6 to 9 in Orlando...
Read more »

Pharmaceutical Industry news



Low Capability Pediatric Hospitals More Than Doubled From 2003 to 2022
ASH: Iron Overload Prevalent in Sickle Cell Disease
ASH: Late Effects Uncommon for Patients With Sickle Cell Disease After Allogeneic HCT
ASH: Sustained Benefit Seen for Etranacogene Dezaparvovec in Hemophilia B
Severity of Sensorineural and Noise-Induced Hearing Loss Increases Throughout Adolescence
GLP-1 Receptor Agonists May Have Little or No Effect on Obesity-Related Cancers
Pegcetacoplan Beneficial for C3 Glomerulopathy, Immune-Complex MPGN
Recommendations Developed for Injury Prevention in Female Athletes
Socioeconomic Factors, Comorbidities Tied to Late-Onset Depression in Long-Term Cancer Survivors
Downstream Harms of Gabapentinoid-Diuretic Prescribing Cascade Often Overlooked
AI-Based Ambient Scribes May Reduce Physician Documentation Time, Burnout
FDA Approves Expanded Indication for Jaypirca
ASH: Agent Orange Exposure Linked to Increased Risk for Myelodysplastic Syndrome
ASH: Few Sickle Cell ED Visits Adhere to Guidelines for Opioid Pain Meds
Desktop versie